Results 41 to 50 of about 478,842 (334)

microRNA-33a-5p increases radiosensitivity by inhibiting glycolysis in melanoma. [PDF]

open access: yes, 2017
Glycolysis was reported to have a positive correlation with radioresistance. Our previous study found that the miR-33a functioned as a tumor suppressor in malignant melanoma by targeting hypoxia-inducible factor1-alpha (HIF-1α), a gene known to promote ...
Cao, Ke   +12 more
core   +1 more source

Primary Pulmonary Malignant Melanoma Presenting as Bilateral Multiple Subsolid Nodules: A Case Report

open access: yes대한영상의학회지, 2022
Primary pulmonary malignant melanoma is an extremely rare type of melanoma. The radiologic features of primary pulmonary malignant melanoma are nonspecific; however, it almost always presents as a well-demarcated round or lobulated solitary solid ...
Eun Gyu Soh   +4 more
doaj   +1 more source

Malignant Melanoma Arising in an Ovarian Mature Cystic Teratoma - A Rare Entity [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Mature cystic teratomas, also known as dermoid cysts, are composed of a mixture of tissues derived from all three germ layers and constitute about 20% of all ovarian neoplasms. However, malignant transformation in a mature cystic teratoma is an uncommon
RANJINI KUDVA   +2 more
doaj   +1 more source

Case report: Type 2 diabetes mellitus with plantar malignant melanoma: Report of two cases

open access: yesFrontiers in Oncology, 2023
Malignant melanoma is a highly malignant tumor that originates from melanocytes. It has a poor prognosis and rarely occurs on the foot. Diabetic foot ulcer is one of the most serious chronic complications of diabetes. This paper reports two cases of type
Bi-Ling Huang   +11 more
doaj   +1 more source

The helicase HAGE prevents interferon-a-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1 [PDF]

open access: yes, 2014
The tumour suppressor PML (promyelocytic leukaemia protein) regulates several cellular pathways involving cell growth, apoptosis, differentiation and senescence.
A Carracedo   +33 more
core   +1 more source

Primary Oral Malignant Melanoma

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2011
Malignant melanoma (MM) is a malignant neoplasm of epidermal melanocytes. Primary malignant melanoma (PMM) is rarely found in the oral cavity. It is estimated at between 0.2 and 8% of all melanomas and approximately four times more frequently in the oral
Panjab V Wanjari   +5 more
doaj   +1 more source

Malignant Melanoma [PDF]

open access: yesHealthcare, 2013
Melanomas are a major cause of premature death from cancer. The gradual decrease in rates of morbidity and mortality has occurred as a result of public health campaigns and improved rates of early diagnosis. Survival of melanoma has increased to over 90%.
Perera, E   +3 more
openaire   +3 more sources

Vitamin D enzymes (CYP27A1, CYP27B1 and CYP24A1) and receptor expression in non-melanoma skin cancer [PDF]

open access: yes, 2019
No abstract available for this ...
Apostolopoulos, Vasso   +4 more
core   +2 more sources

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira   +14 more
wiley   +1 more source

Worldwide Cutaneous Malignant Melanoma Incidences Analyzed by Sex, Age, and Skin Type Over Time (1955–2007): Is HPV Infection of Androgenic Hair Follicular Melanocytes a Risk Factor for Developing Melanoma Exclusively in People of European-Ancestry? [PDF]

open access: yes, 2016
The cutaneous malignant melanoma (CMM) incidence has been increasing in an exponential manner in certain populations around the world for over 7 decades.
Merrill, Stephen   +2 more
core   +3 more sources

Home - About - Disclaimer - Privacy